Prenatal and Perinatal Factors Associated with Infant Acute Lymphoblastic Leukaemia: A Scoping Review

Arantza Sanvisens1,2, Clara Bueno3,4,5, Oriol Calvete6

  • 1Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Catalan Cancer Plan, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI-CERCA), 17004 Girona, Spain.

Cancers
|February 13, 2025
PubMed

Insights

This review explored prenatal and perinatal risk factors for infant acute lymphoblastic leukaemia (ALL). Findings suggest links between infant ALL and maternal pesticide exposure, high birth weight, parental smoking, certain medications, and air pollution.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Environmental Health

Background:

  • Infant acute lymphoblastic leukaemia (ALL) (<1 year) has a poor prognosis, particularly with KMT2A rearrangements.
  • Identifying prenatal and perinatal risk factors for infant ALL is challenging due to limited sample sizes in epidemiological studies.

Purpose of the Study:

  • To conduct a scoping review to identify prenatal or perinatal factors associated with infant ALL.
  • To elucidate potential risk factors contributing to the development of ALL in infants.

Main Methods:

  • A comprehensive scoping review of original articles, letters, and conference abstracts.
  • Literature search conducted across PubMed, Web of Science, and Embase databases up to June 2022.
  • Selection of 33 observational studies for analysis.

Main Results:

  • Established associations include maternal pesticide exposure and high birth weight.
  • Suggestive associations identified: parental heavy smoking, parental use of medications (e.g., dipyrone), and maternal exposure to air pollution during pregnancy.

Conclusions:

  • This review summarizes observational studies on prenatal/perinatal risk factors for infant ALL.
  • Highlights a significant gap in research for this specific pediatric age group.
  • Emphasizes the need for further investigation into infant ALL risk factors.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
282
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
895
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
838
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K